Status:
NOT_YET_RECRUITING
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
Lead Sponsor:
Tamara C Tamas
Conditions:
Post-Acute Sequelae of SARS-CoV-2 Infection
Long COVID
Eligibility:
All Genders
18-65 years
Brief Summary
This observational study is being conducted by Healing Hope International to collect real-world data on an emerging treatment approach for Long COVID in patients with immunodeficiency. The study inves...
Detailed Description
This observational study, initiated by Healing Hope International, is designed to collect real-world data (RWD) from individuals diagnosed with Long COVID who are undergoing clinical care involving in...
Eligibility Criteria
Inclusion
- Age 18 to 65 years
- Clinical diagnosis of Long COVID (symptoms persisting ≥12 weeks after SARS-CoV-2 infection)
- Laboratory-confirmed immunodeficiency, including one or more of the following:
- Low serum IgG and/or IgA
- Specific antibody deficiency
- Low pneumonia titers
- Elevated inflammatory markers (e.g., CRP, cytokines)
- No active infections at the time of enrollment (bacterial, viral, or fungal)
- Negative for Lyme disease and NMDAR antibodies
- Willingness to provide informed consent for data collection and use
Exclusion
- Current or recent active infection (e.g., viral, bacterial, or fungal)
- Use of immunosuppressive therapy within the last 3 months
- Active infections: Participants with active infections, including viral, bacterial, or fungal infections, will be excluded
- Neurological disorders: Participants with diagnosed neurological disorders (e.g., multiple sclerosis, Parkinson's disease, Alzheimer's disease) will be excluded
- Immunosuppressive therapy: Participants receiving immunosuppressive therapy will be excluded
- Inability to comply with study assessments or procedures
Key Trial Info
Start Date :
August 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2029
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06992401
Start Date
August 1 2026
End Date
July 15 2029
Last Update
December 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.